All these data suggest that the autophagy-lysosomal pathway plays a critical role in the clearance of apoA-I fibrils and that targeting of autophagy and lysosomes may be an attractive strategy for treatment of AApoA1 amyloidosis. The gene discussed is APOA1; the disease is amyloidosis.